Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Anus Neoplasms × durvalumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27 Lung Neoplasms 12 Colorectal Neoplasms 11 Ovarian Neoplasms 10 Breast Neoplasms 10 Small Cell Lung Carcinoma 8 Urinary Bladder Neoplasms 7 Recurrence 6 Prostatic Neoplasms 6 Neoplasms 6 Head and Neck Neoplasms 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Neoplasms 5 Diabetes Mellitus, Insulin-Dependent, 12 5 Carcinoma, Hepatocellular 5 Carcinoma 5 Neoplasm Metastasis 4 Recurrent Squamous Cell Lung Carcinoma 3 Multiple Myeloma 3 Mouth Neoplasms 3 Mesothelioma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Kidney Neoplasms 3 Esophageal Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Urothelial Cancer 2

Interventions

Fluorouracil 7 Radiotherapy 4 Mitomycin 3 Cyclophosphamide 3 Cisplatin 3 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 Watchful Waiting 2 Light Coagulation 2 Cetuximab 2 Biopsy 2 tempol 1 pembrolizumab 1 enzalutamide 1 dehydroftorafur 1 alovudine 1 abiraterone 1 Yoga 1 VGX-3100 1 Therapeutics 1 Specimen Handling 1 Proton Therapy 1 Polymerase Chain Reaction 1 Platinum 1 Papillomavirus Vaccines 1 Palonosetron 1 Oxaliplatin 1 Observation 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡